<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cardiovasc Intervent Radiol</journal-id>
      <journal-title-group>
        <journal-title>Cardiovascular and Interventional Radiology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0174-1551</issn>
      <issn pub-type="epub">1432-086X</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3096768</article-id>
      <article-id pub-id-type="pmid">20593287</article-id>
      <article-id pub-id-type="publisher-id">9927</article-id>
      <article-id pub-id-type="doi">10.1007/s00270-010-9927-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Investigation</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Endovascular Stent Treatment for Symptomatic Benign Iliofemoral Venous Occlusive Disease: Long-Term Results 1987&#x2013;2009</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Gutzeit</surname>
            <given-names>A.</given-names>
          </name>
          <address>
            <email>andreas.gutzeit@ksw.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zollikofer</surname>
            <given-names>Ch. L.</given-names>
          </name>
          <address>
            <email>Christoph.Zollikofer@ksb.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dettling-Pizzolato</surname>
            <given-names>M.</given-names>
          </name>
          <address>
            <email>Mira.Dettling@ksw.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Graf</surname>
            <given-names>N.</given-names>
          </name>
          <address>
            <email>nicole.graf@usz.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Largiad&#xE8;r</surname>
            <given-names>J.</given-names>
          </name>
          <address>
            <email>jon.largiader@gefaesschirurgie-zuerich.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Binkert</surname>
            <given-names>C. A.</given-names>
          </name>
          <address>
            <email>christoph.binkert@ksw.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Radiology, Cantonal Hospital Winterthur, Brauerstrasse 15, 8401 Winterthur, Switzerland </aff>
        <aff id="Aff2"><label>2</label>Clinical Trials Center, Center for Clinical Research, University Hospital of Zurich, 8091 Zurich, Switzerland </aff>
        <aff id="Aff3"><label>3</label>Department of Surgery, Klinik Im Park, 8027 Zurich, Switzerland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <volume>34</volume>
      <issue>3</issue>
      <fpage>542</fpage>
      <lpage>549</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>4</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>Venous stenting has been shown to effectively treat iliofemoral venous obstruction with good short- and mid-term results. The aim of this study was to investigate long-term clinical outcome and stent patency. Twenty patients were treated with venous stenting for benign disease at our institution between 1987 and 2005. Fifteen of 20 patients (15 female, mean age at time of stent implantation 38&#xA0;years [range 18&#x2013;66]) returned for a clinical visit, a plain X-ray of the stent, and a Duplex ultrasound. Four patients were lost to follow-up, and one patient died 277&#xA0;months after stent placement although a good clinical result was documented 267&#xA0;months after stent placement. Mean follow-up after stent placement was 167.8&#xA0;months (13.9&#xA0;years) (range 71 (6&#xA0;years) to 267&#xA0;months [22&#xA0;years]). No patient needed an additional venous intervention after stent implantation. No significant difference between the circumference of the thigh on the stented side (mean 55.1&#xA0;cm [range 47.0&#x2013;70.0]) compared with the contralateral thigh (mean 54.9&#xA0;cm [range 47.0&#x2013;70.0]) (<italic>p</italic>&#xA0;=&#xA0;0.684) was seen. There was a nonsignificant trend toward higher flow velocities within the stent (mean 30.8&#xA0;cm/s [range 10.0&#x2013;48.0]) and the corresponding vein segment on the contralateral side (mean 25.2&#xA0;cm/s [range 12.0&#x2013;47.0]) (<italic>p</italic>&#xA0;=&#xA0;0.065). Stent integrity was confirmed in 14 of 15 cases. Only one stent showed a fracture, as documented on x-ray, without any impairment of flow. Venous stenting using Wallstents showed excellent long-term clinical outcome and primary patency rate.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Iliofemoral venous stent</kwd>
        <kwd>Benign venous stenosis</kwd>
        <kwd>Long-term result</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>Benign iliofemoral venous occlusion is often difficult to treat. The main goal is to improve patient quality of life and prevent chronic venous insufficiency (CVI), which may lead to an inability to work [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>In the past, different surgical techniques involving venous bypass were used in cases of iliocaval venous obstruction [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. The main problem with bypass surgery is its invasiveness and associated complications. The reported outcomes are rather poor, with patency rates between 54 and 84%. Therefore, this therapy option is rarely used today [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>In 1985, the first use of a self-expanding stent was described in the venous system of a dog [<xref ref-type="bibr" rid="CR6">6</xref>]. Soon afterward the first studies in humans were published [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. Good short- and mid-term patency rates were reported in these publications; however, the question of long-term clinical outcome and stent patency remained unanswered. The aim of the present study was to investigate clinical outcome as well as stent patency and integrity after follow-up &gt;5&#xA0;years.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <p>The study was approved by our Institutional Review Board. Written informed consent was obtained from all patients.</p>
      <sec id="Sec3">
        <title>Patients</title>
        <p>From January 1987 to October 2005, 20 patients were admitted to our department for endovenous treatment of benign iliofemoral stenosis or occlusion. Five patients were excluded from further analysis. Four of these five patients were lost to follow-up. One patient died 277&#xA0;months (23&#xA0;years) after common iliac vein stent placement from a cause unrelated to the venous stent. For this patient, the last clinical visit 267&#xA0;months (22&#xA0;years) after stent placement showed a good clinical outcome after iliac vein stenting with no leg swelling. Fifteen patients (all female; mean age at time of stent implantation 38&#xA0;years [range 18&#x2013;66]) were included in the study. The etiology of obstruction was iatrogenic stenosis of an iliofemoral vein in four cases (patients no. 1, 2, 6, and 11) and stenosis of a venous interposition graft of the superficial femoral (patient no. 12) and the common femoral veins (patient 14). Six patients were treated with stents after thrombectomy for pelvic vein thrombosis caused by May&#x2013;Thurner syndrome (patients no. 3, 7, 8, 9, 10, and 15). Two patients were stented after recanalization of a chronic postthrombotic obstruction of the common and/or external iliac veins (patient no. 5 and 13). One patient was treated with common iliac vein stent during treatment of an acute four-level thrombosis (patient no. 4). Details concerning patient data are listed in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Summary of patient data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient no.</th><th align="left">Age at time of stent placement (y)</th><th align="left">Follow-up (mo)</th><th align="left">Indication for stent insertion</th><th align="left">Stent localisation</th><th align="left">Wallstent size (mm)</th><th align="left">Stent integrity</th><th align="left">Velocity within stent and corresponding contralateral segment (cm/s)</th><th align="left" colspan="2">Diameter of the thigh and the calf of the leg with the stent compared with the contralateral side (cm)</th></tr></thead><tbody><tr><td align="left" rowspan="3">1</td><td align="left" rowspan="3">66</td><td align="left" rowspan="3">219</td><td align="left" rowspan="3">Iatrogenic stenosis after crossectomy for varicose veins</td><td align="left" rowspan="3">Common femoral vein left</td><td align="left" rowspan="3">14/50</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">10 within stent, 20 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 53</td><td align="left">Thigh: 53</td></tr><tr><td align="left">Lower part: 34</td><td align="left">Lower part: 33</td></tr><tr><td align="left" rowspan="3">2</td><td align="left" rowspan="3">46</td><td align="left" rowspan="3">196</td><td align="left" rowspan="3">Iatrogenic stenosis due to a hematoma after coronary angiography</td><td align="left" rowspan="3">External iliac vein right</td><td align="left" rowspan="3">14/50</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">18 within stent, 15 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 49</td><td align="left">Thigh: 50</td></tr><tr><td align="left">Lower part: 33</td><td align="left">Lower part: 34</td></tr><tr><td align="left" rowspan="3">3</td><td align="left" rowspan="3">47</td><td align="left" rowspan="3">171</td><td align="left" rowspan="3">May-Thurner syndrome with acute thrombosis.</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">16/60</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">30 within stent, 20 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 55</td><td align="left">Thigh: 54</td></tr><tr><td align="left">Lower part: 40</td><td align="left">Lower part: 41</td></tr><tr><td align="left" rowspan="3">4</td><td align="left" rowspan="3">18</td><td align="left" rowspan="3">111</td><td align="left" rowspan="3">Factor V Leiden mutation and acute 4-level thrombosis of the left leg</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">16/90</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">20 within stent; 47 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 70</td><td align="left">Thigh: 70</td></tr><tr><td align="left">Lower part:4 4</td><td align="left">Lower part: 44</td></tr><tr><td align="left" rowspan="3">5</td><td align="left" rowspan="3">54</td><td align="left" rowspan="3">180</td><td align="left" rowspan="3">Chronic thrombosis of the iliac vein; massive signs of CVI despite operative Palma shunt with persistent AV shun.</td><td align="left" rowspan="3">Common iliac vein&#xA0;+&#xA0;external iliac vein left</td><td align="left" rowspan="3">12/89; 12/66; 14/96; 16/6.1</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">41 within stent, 13 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 57</td><td align="left">Thigh: 57</td></tr><tr><td align="left">Lower part: 42</td><td align="left">Lower part: 41</td></tr><tr><td align="left" rowspan="3">6</td><td align="left" rowspan="3">45</td><td align="left" rowspan="3">205</td><td align="left" rowspan="3">Iatrogenic thrombosis of the common iliac vein left after crossectomy</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">16/90</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">43 within stent; 30 contralateral side</td><td align="left">Stent extremity</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 65</td><td align="left">Thigh: 59</td></tr><tr><td align="left">Lower part: 36</td><td align="left">Lower part: 31</td></tr><tr><td align="left" rowspan="3">7</td><td align="left" rowspan="3">40</td><td align="left" rowspan="3">186</td><td align="left" rowspan="3">Chronic left pelvic vein thrombosis in the case of May-Thurner syndrome and persistent pressure gradient despite a Palma shunt</td><td align="left" rowspan="3">Common and external iliac vein left</td><td align="left" rowspan="3">10/60; 12/60; 14/60</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">44 within stent; 33 contralateral side</td><td align="left"><bold>Stent extremity</bold>:</td><td align="left"><bold>Nonstent extremity:</bold></td></tr><tr><td align="left">Thigh: 53</td><td align="left">Thigh: 58</td></tr><tr><td align="left">Lower part: 40</td><td align="left">Lower part: 37</td></tr><tr><td align="left" rowspan="3">8</td><td align="left" rowspan="3">50</td><td align="left" rowspan="3">168</td><td align="left" rowspan="3">May-Thurner syndrome with acute thrombosis</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">16/90</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">15 within stent; 20 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 54</td><td align="left">Thigh: 54</td></tr><tr><td align="left">Lower part: 37</td><td align="left">Lower part: 37</td></tr><tr><td align="left" rowspan="3">9</td><td align="left" rowspan="3">18</td><td align="left" rowspan="3">71</td><td align="left" rowspan="3">May-Thurner syndrome with acute thrombosis</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">14/70</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">24 within stent; 19 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 61</td><td align="left">Thigh: 60</td></tr><tr><td align="left">Lower part: 41</td><td align="left">Lower part: 40</td></tr><tr><td align="left" rowspan="3">10</td><td align="left" rowspan="3">23</td><td align="left" rowspan="3">148</td><td align="left" rowspan="3">May-Thurner syndrome with acute thrombosis</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">12/80</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">43 within stent; 33 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 47</td><td align="left">Thigh: 47</td></tr><tr><td align="left">Lower part: 35</td><td align="left">Lower part: 35</td></tr><tr><td align="left" rowspan="3">11</td><td align="left" rowspan="3">41</td><td align="left" rowspan="3">135</td><td align="left" rowspan="3">Iatrogenic stenosis after venous stripping</td><td align="left" rowspan="3">Common femoral vein right</td><td align="left" rowspan="3">12/80</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">21&#xA0;cm/seconds within the stent 12&#xA0;cm/seconds contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 51</td><td align="left">Thigh:52</td></tr><tr><td align="left">Lower part:35</td><td align="left">Lower part:35</td></tr><tr><td align="left" rowspan="3">12</td><td align="left" rowspan="3">34</td><td align="left" rowspan="3">222&#xA0;months</td><td align="left" rowspan="3">Stenosis after jugular vein interponate in the common femoral vein after iatrogenic transection</td><td align="left" rowspan="3">Common femoral vein right</td><td align="left" rowspan="3">2&#xA0;&#xD7;&#xA0;12/75</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">48 within stent; 40 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 47</td><td align="left">Thigh: 48</td></tr><tr><td align="left">Lower part: 30</td><td align="left">Lower part: 33</td></tr><tr><td align="left" rowspan="3">13</td><td align="left" rowspan="3">31</td><td align="left" rowspan="3">83</td><td align="left" rowspan="3">Chronic thrombosis after hip surgery and factor V Leiden mutation</td><td align="left" rowspan="3">Common femoral vein left</td><td align="left" rowspan="3">12/90; 14/90</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">30 within stent; 28 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 49</td><td align="left">Thigh:48</td></tr><tr><td align="left">Lower part:34</td><td align="left">Lower part:33</td></tr><tr><td align="left" rowspan="3">14</td><td align="left" rowspan="3">33</td><td align="left" rowspan="3">267</td><td align="left" rowspan="3">Stab wound injury; stenosis of the jugular vein interponate</td><td align="left" rowspan="3">Superficial femoral vein right</td><td align="left" rowspan="3">2&#xA0;&#xD7;&#xA0;14/70</td><td align="left" rowspan="3">Stent fracture</td><td align="left" rowspan="3">30 within stent; 28 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 61</td><td align="left">Thigh: 60</td></tr><tr><td align="left">Lower part: 49</td><td align="left">Lower part: 48</td></tr><tr><td align="left" rowspan="3">15</td><td align="left" rowspan="3">24</td><td align="left" rowspan="3">155</td><td align="left" rowspan="3">May-Thurner syndrome with acute thrombosis</td><td align="left" rowspan="3">Common iliac vein left</td><td align="left" rowspan="3">14/80</td><td align="left" rowspan="3">Yes</td><td align="left" rowspan="3">45 within stent; 20 contralateral side</td><td align="left">Stent extremity:</td><td align="left">Nonstent extremity:</td></tr><tr><td align="left">Thigh: 55</td><td align="left">Thigh: 54</td></tr><tr><td align="left">Lower part: 36</td><td align="left">Lower part: 34</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Venous Intervention</title>
        <p>The procedure was performed in the interventional suite using either an ipsilateral retrograde percutaneous femoral vein access in cases of a common or external iliac vein obstruction or a crossover technique in cases of a common femoral vein stenosis. In one patient with a long-standing occlusion of the common and external iliac veins, a transjugular approach had to be used (patient no. 5). In all patients, self-expanding Wallstents (Boston Scientific, Natick, MA) were used (details of stent dimensions are listed in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). We did not use other stent types. In the cases of iatrogenic or postoperative stenoses as well as chronic obstruction, a probatory test balloon angioplasty was performed to evaluate adequate stent size. The Wallstent was oversized by at least 1&#xA0;mm. In cases of insufficient spontaneous self-expansion after placement, the stent was dilated to the estimated diameter of the treated vein. During the procedure, 5000 U heparin were administrated intravenously. After stent placement all patients were treated routinely with warfarin for 6&#xA0;months. Patients no. 4 and 13 (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) had a factor V Leiden mutation, which was treated with long-term therapy during the entire observation period.</p>
      </sec>
      <sec id="Sec5">
        <title>Follow-Up</title>
        <p>Follow-up was conducted from October 2009 to November 2009. Follow-up included a clinical examination with measurement of leg circumferences, Duplex ultrasound, and x-ray of the stent. Fourteen of 15 follow-up examinations were performed at the institution where the stents were placed. In one case (patient no. 14), the follow-up examination was performed in another hospital overseas.</p>
      </sec>
      <sec id="Sec6">
        <title>Clinical Investigation</title>
        <p>The patients were questioned for any intervention or surgery concerning their veins after stent placement. Signs of venous insufficiency, including varicosities and ulcers were recorded. Maximum circumferences of the thighs and calves were measured.</p>
      </sec>
      <sec id="Sec7">
        <title>Duplex Ultrasound</title>
        <p>The patients were examined using a state-of-the-art ultrasound scanner (Acuson Sequoia 512; Siemens, Munich, Germany). 4- and 8-MHz probes were used. The presence or absence of venous flow through the stent was investigated. In addition, maximum velocities within the stent and the contralateral untreated vein were recorded. Furthermore, it was documented if there was venous reflux under Valsalva maneuver.</p>
      </sec>
      <sec id="Sec8">
        <title>X-Ray</title>
        <p>Plain X-ray of the stent area was performed in anteroposterior view. In 14 patients, a film of the pelvis was obtained, and a film of the thigh was taken in one patient (patient no. 14). X-rays were analyzed for stent fractures on a PACS system (Impax 4.2, Agfa) that allowed magnified and inverted views.</p>
      </sec>
      <sec id="Sec9">
        <title>Statistical Analysis</title>
        <p>Statistical analyses were performed using the statistical program SPSS version 17 (SPSS version 17.0.1; SPSS, Chicago, IL). The data were analyzed, and a mean of the circumferences of the treated and nontreated legs, as well as flow measurements within the stent, were evaluated. Wilcoxon signed-rank test was used for comparisons within paired samples.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Results</title>
      <sec id="Sec11">
        <title>Clinical Outcome</title>
        <p>Mean follow-up after stent placement was 167.8&#xA0;months (13.9&#xA0;years) (range 71&#x2013;267 [6 to 22&#xA0;years]). No patient needed any additional intervention after stent implantation.</p>
        <p>Two patients showed mild varicosis (patients no. 3 and 5), which had existed before venous stenting. In one patient, severe venous insufficiency (patient no. 6) with chronic venous ulcers was detected. This patient had severe varicosity documented before the intervention.</p>
        <p>No significant difference (<italic>p</italic>&#xA0;=&#xA0;0.684) between the circumference of the thigh on the stented side (mean 55.1&#xA0;cm [range 47.0&#x2013;70.0]) and the contralateral thigh (mean 54.9&#xA0;cm [range 47.0&#x2013;70.0]) was found. There was a nonsignificant tendency toward a greater circumference of the calf on the treated side (mean 37.7&#xA0;cm [range 30.0&#x2013;49.0]) compared with the nontreated side (mean 37.1&#xA0;cm [range 31.0&#x2013;48.0]) (<italic>p</italic>&#xA0;=&#xA0;0.191).</p>
      </sec>
      <sec id="Sec12">
        <title>Duplex Ultrasound</title>
        <p>All stents were patent and had respiratory variation of flow. No stenosis or occlusion within the stent was seen. There was a nonsignificant trend of higher flow velocities within the stent compared with the corresponding segment of the contralateral side (<italic>p</italic>&#xA0;=&#xA0;0.065). The median maximal velocity within the stent was 30.0&#xA0;cm/s (range 10&#x2013;48), and the median maximal velocity of the contralataral side was 20.0&#xA0;cm/s (range 12&#x2013;47). No patient showed venous reflux under the Valsalva maneuver within the stented segment.</p>
      </sec>
      <sec id="Sec13">
        <title>X-Ray</title>
        <p>Stent integrity, with normal stent morphology, was documented in 14 of 15 cases (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). One stent showed a single stent fracture (patient no. 14). We guess that the reason for this fracture was a calcified hematoma adjacent to the stent, which resulted in chronic mechanical stress (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>A&#x2013;F). It is remarkable that even stents placed in the common femoral vein directly over the hip joint (patients no. 1 and 11 through 13) showed no fracture after 83 to 222&#xA0;months later (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>A, B).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Shows X-ray of the pelvis, including a magnified view demonstrating the integrity of the stent in the left common iliac vein 13&#xA0;years after placement for acute thrombosis due to a May&#x2013;Thurner syndrome</p></caption><graphic xlink:href="270_2010_9927_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Serial venograms during a follow-up period of 22&#xA0;years (patient no. 14) after a stab wound injury of the right superficial femoral vein, which was treated with a venous interposition graft, resulting in stenosis of the femoral vein. <bold>A</bold> Venogram shows severe stenosis corresponding to the venous interposition graft. <bold>B</bold> Venogram taken after placement of two 14&#xA0;&#xD7;&#xA0;70-mm Wallstents in the superficial femoral vein. <bold>C</bold> Venogram taken 4&#xA0;years later shows new soft-tissue calcification adjacent to the patent stent (<italic>arrow</italic>), which was interpreted as a calcified hematoma or myositis ossificans. The stent is intact at follow-up of 6, 8, and 22&#xA0;years. <bold>D</bold>, <bold>F</bold> A stent fracture can be noticed (<italic>curved arrow</italic>), which remained mostly unchanged over the years, with no signs of flow impairment or clinical signs of leg swelling. The likely cause of the stent fracture can be identified as the pointed part of the calcification (<italic>arrow</italic>) interfering with the stent</p></caption><graphic xlink:href="270_2010_9927_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p><bold>A</bold> X-ray of the right hip in a bent position after placement of two 12&#xA0;&#xD7;&#xA0;75-mm Wallstents in the common femoral vein (patient no. 12) shows good adaption of the Wallstent to the curving course of the common femoral vein, with no signs of kinking or damage to the stent The upper and lower edges of the stent are marked with arrows. <bold>B</bold> X-ray of the hip of the same patient 18.5&#xA0;years after placement shows that the Wallstent remained intact</p></caption><graphic xlink:href="270_2010_9927_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Discussion</title>
      <p>Our data suggest that stenting of benign iliofemoral venous obstruction has a good long-term clinical outcome with excellent stent patency. After a mean follow-up of 167.8&#xA0;months (13.9&#xA0;years), no additional venous intervention was needed in any patient. There was no significant leg swelling of the stented extremity compared with the contralateral side.</p>
      <p>Since its introduction in the mid-1980&#xA0;s, venous stenting has become a widely accepted treatment option [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>]. Venous stenting has replaced surgical techniques, such as the Palma operation or the axial bypass technique for venous obstruction [<xref ref-type="bibr" rid="CR15">15</xref>]. Not only is surgery more invasive than stenting, it also shows low patency rates between 44% and 85% [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>Few reports about the mid- and long-term results after stenting of benign iliocaval obstructions [<xref ref-type="bibr" rid="CR17">17</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>] have shown patency rates approaching 100% without any stent fractures or other stent-related complications.</p>
      <p>Our study focused on long-term outcomes &gt;5&#xA0;years. The results confirm excellent long-term result, with a patency rate of 100%, which corresponds to the good clinical outcome as measured by the lack of leg swelling.</p>
      <p>Stent integrity has generally not been assessed in the venous system in the published literature [<xref ref-type="bibr" rid="CR17">17</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>] compared with the arterial system, in which stent fractures are of concern, particularly in the lower extremity [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. We encountered only one stent fracture (6.7%) in a special situation, <italic>i.e.</italic>, the stent was placed in the superficial femoral vein (patient no. 14). During follow-up, soft-tissue calcifications developed lateral to the stent, which led to focal stent fracture after 6&#xA0;years. The stent remained patent without any impairment of flow, despite the fracture, during a follow-up of 22&#xA0;years.</p>
      <p>Interestingly, no fractures were seen in the four stents placed in the common femoral vein across the hip joint. One patient (patient no. 15) with a common iliac stent had a normal pregnancy without any damage to the stent.</p>
      <p>In the present study, patients were treated with warfarin for 6&#xA0;months. Thereafter, no further anticoagulation was given routinely. Because no thrombosis occurred during our study, long-term anticoagulation did not seem necessary. The ability to stop anticoagulation is helpful because long-term anticoagulation during a period of years has its own risks [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
      <p>Our study has several limitations. First, we only include a small study group, especially in the age group &lt;50&#xA0;years. Therefore, the long-term results should be interpreted with caution. The second limitation is the use a single device type (Wallstent), and the third limitation is the variety of underlying causes for venous obstruction.</p>
      <p>In conclusion, venous stenting with Wallstents showed an excellent patency rate with good clinical outcomes between 71&#xA0;months (6&#xA0;years) and 267&#xA0;months (22&#xA0;years).</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that they have no conflict of interest.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meissner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Eklof</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>PC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Secondary chronic venous disorders</article-title>
          <source>J Vasc Surg</source>
          <year>2007</year>
          <volume>46</volume>
          <issue>Suppl S</issue>
          <fpage>68S</fpage>
          <lpage>83S</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jvs.2007.08.048</pub-id>
          <pub-id pub-id-type="pmid">18068563</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alimi</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fabre</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Juhan</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Iliac vein reconstructions to treat acute and chronic venous occlusive disease</article-title>
          <source>J Vasc Surg</source>
          <year>1997</year>
          <volume>25</volume>
          <fpage>673</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="doi">10.1016/S0741-5214(97)70294-5</pub-id>
          <pub-id pub-id-type="pmid">9129623</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jost</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Gloviczki</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>KJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease</article-title>
          <source>J Vasc Surg</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>320</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="doi">10.1067/mva.2001.112805</pub-id>
          <pub-id pub-id-type="pmid">11174784</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alimi</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Juhan</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>New trends in the surgical and endovascular reconstructions of large veins for nonmalignant chronic venous occlusive disease</article-title>
          <source>Curr Opin Cardiol</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>375</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="doi">10.1097/00001573-199809000-00010</pub-id>
          <pub-id pub-id-type="pmid">9823793</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Halliday</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bergan</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>JST</given-names>
            </name>
          </person-group>
          <article-title>Femoro-femoral crossover grafts (Palma operation): a long-term follow up study</article-title>
          <source>Surgery of the veins</source>
          <year>1985</year>
          <publisher-loc>Orlando</publisher-loc>
          <publisher-name>Grune &amp; Stratton</publisher-name>
          <fpage>241</fpage>
          <lpage>254</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Charnsangavej</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carrasco</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Gianturco</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Percutaneous endovascular stents: an experimental evaluation</article-title>
          <source>Radiology</source>
          <year>1985</year>
          <volume>156</volume>
          <fpage>69</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">4001423</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zollikofer</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Largiader</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bruhlmann</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Uhlschmid</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Marty</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Endovascular stenting of veins and grafts: Preliminary clinical experience</article-title>
          <source>Radiology</source>
          <year>1988</year>
          <volume>167</volume>
          <fpage>707</fpage>
          <lpage>712</lpage>
          <pub-id pub-id-type="pmid">2966417</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antonucci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Salomonowitz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stuckmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stiefel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Largiad&#xE8;r</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zollikofer</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Placement of venous stents: clinical experience with a self-expanding prosthesis</article-title>
          <source>Radiology</source>
          <year>1992</year>
          <volume>183</volume>
          <fpage>493</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="pmid">1561356</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zollikofer</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Antonucci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Stuckmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mattias</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Br&#xFC;hlmann</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Salomonowitz</surname>
              <given-names>EK</given-names>
            </name>
          </person-group>
          <article-title>Use of the Wallstent in the venous system including hemodialysis-related stenoses</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>1992</year>
          <volume>15</volume>
          <fpage>334</fpage>
          <lpage>341</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02733959</pub-id>
          <pub-id pub-id-type="pmid">1423395</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oguzkurt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tercan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ozkan</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gulcan</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up</article-title>
          <source>Eur J Radiol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>487</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejrad.2007.08.019</pub-id>
          <pub-id pub-id-type="pmid">17900842</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzbach</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>B&#xF6;ckler</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical thrombectomy followed by intraoperative endovascular reconstruction for symptomatic ilio-femoral venous thrombosis</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>58</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejvs.2004.09.022</pub-id>
          <pub-id pub-id-type="pmid">15570273</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Negl&#xE9;n</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hollis</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Olivier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raju</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Stenting of the venous outflow in chronic venous disease: Long-term stent-related outcome, clinical, and hemodynamic result</article-title>
          <source>J Vasc Surg</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>979</fpage>
          <lpage>990</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jvs.2007.06.046</pub-id>
          <pub-id pub-id-type="pmid">17980284</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Nazarian</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Hartenbach</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of pelvic venous stenosis with intravascular stainless steel stents</article-title>
          <source>Gynecol Oncol</source>
          <year>1995</year>
          <volume>56</volume>
          <fpage>362</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1006/gyno.1995.1064</pub-id>
          <pub-id pub-id-type="pmid">7705669</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ley</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Hood</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Leke</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Endovascular management of iliac vein occlusive disease</article-title>
          <source>Ann Vasc Surg</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>228</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="doi">10.1007/s10016-003-0096-9</pub-id>
          <pub-id pub-id-type="pmid">15253261</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palma</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Esperon</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Treatment of the post-thrombophlebitic syndrome by means of internal saphenous transplants</article-title>
          <source>Bol Soc Cir Urug</source>
          <year>1959</year>
          <volume>30</volume>
          <fpage>115</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="pmid">14429962</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolaides</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Allegra</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bergan</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence</article-title>
          <source>Int Angiol</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>1</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">18277340</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;lbel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lindh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akesson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wass&#xE8;lius</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gotts&#xE4;ter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ivancev</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Chronic iliac vein occlusion: midterm results of endovascular recanalization</article-title>
          <source>J Endovasc Ther</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>483</fpage>
          <lpage>491</lpage>
          <pub-id pub-id-type="doi">10.1583/09-2719.1</pub-id>
          <pub-id pub-id-type="pmid">19702343</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hartung</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Loundou</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Barthelemy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Arnoux</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Boufi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alimi</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Endovascular management of chronic disabling ilio-caval obstructive lesions: Long-term results</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2009</year>
          <volume>38</volume>
          <fpage>118</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejvs.2009.03.004</pub-id>
          <pub-id pub-id-type="pmid">19356954</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hartung</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Otero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boufi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease</article-title>
          <source>J Vasc Surg</source>
          <year>2005</year>
          <volume>42</volume>
          <fpage>1138</fpage>
          <lpage>1144</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jvs.2005.08.012</pub-id>
          <pub-id pub-id-type="pmid">16376204</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hartung</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Benmiloud</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Barthelemy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dubuc</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boufi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alimi</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Late results of surgical venous thrombectomy with iliocaval stenting</article-title>
          <source>J Vasc Surg</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>381</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jvs.2007.10.007</pub-id>
          <pub-id pub-id-type="pmid">18241761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wohlgemuth</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Loeprecht</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tietze</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bohndorf</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>PTA and stenting of benign venous stenoses in the pelvis: Long-term results</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>9</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1007/s002709910002</pub-id>
          <pub-id pub-id-type="pmid">10656901</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nazir</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ganeshan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nazir</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Uberoi</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Endovascular treatment options in the management of lower limb deep venous thrombosis</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>2009</year>
          <volume>32</volume>
          <fpage>861</fpage>
          <lpage>876</lpage>
          <pub-id pub-id-type="doi">10.1007/s00270-009-9662-z</pub-id>
          <pub-id pub-id-type="pmid">19641957</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boehm</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gschwendtner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schillinger</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Carotid stent fracture: diagnosis and management</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2009</year>
          <volume>74</volume>
          <fpage>273</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">19363810</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlager</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Dick</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sabeti</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-segment SFA stenting&#x2014;the dark sides: in-stent restenosis, clinical deterioration, and stent fractures</article-title>
          <source>J Endovasc Ther</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>676</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="doi">10.1583/05-1672.1</pub-id>
          <pub-id pub-id-type="pmid">16363897</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="other">Wells PS, Forgie MA, Simms M (2003) The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med 163:917&#x2013;920</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
